TTK was expressed at higher levels in ovarian cancer (Fig. 1C and Supplementary Fig. S1A–C) and other cancers (Supplementary Fig. S1D) than in the corresponding normal controls in several open access databases. Here, TTK is linked to ovarian cancer.